Test Code Billings Clinic: 1920 Quest: 34949 HIV-1 Genotype
Performing Laboratory
Quest Diagnostics Infectious Disease
Useful For
HIV-1 Genotype - This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test identifies drug resistance-associated mutations in the HIV-1 protease and reverse transcriptase genes. It can be used to predict antiretroviral drug resistance before initiation of therapy and in patients experiencing virologic failure while on therapy.
Methodology
DNA Sequencing • Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Specimen Requirements
Preferred Specimen(s):
2 mL plasma collected in an EDTA (lavender-top) tube
Minimum Volume
0.6 mL
Collection Instructions
- Freshly drawn specimens (whole blood) may be stored at 2° C to 25° C for up to 24 hours prior to centrifugation.
- Separate plasma from cells within 24 hours of collection by centrifugation.
Tranport Temperature
Frozen
Storage/Stability
Specimen Type | Temperature | Time |
EDTA Plasma | Refrigerated | 6 days |
Frozen (preferred) | 42 days | |
Ambient | 24 hours |
Reject Due To
- Serum
- Specimens sent frozen in the original collection tube
- Whole blood >24 hours old
- Frozen whole blood
Reference Values
See Laboratory Report
Day(s) Test Set Up
Set up: Daily
Report Available: 4 - 9 days
Test Classification and CPT Coding
87900 - Infectious agent drug susceptibility phenotype prediction using regularly updated genotypic bioinformatics
87901 - Infectious agent genotype analysis by nucleic acid (DNA or RNA); HIV-1, reverse transcriptase and protease regions
LOINC Code Information
48558-1 HIV Genotype
Profile/Testing Information
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.